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Abstract
Pools of mutants of minimal complexity but maximal coverage of genes of interest facilitate screening for genes under
selection in a particular environment. We constructed individual deletion mutants in 1,023 Salmonella enterica serovar
Typhimurium genes, including almost all genes found in Salmonella but not in related genera. All mutations were confirmed
simultaneously using a novel amplification strategy to produce labeled RNA from a T7 RNA polymerase promoter,
introduced during the construction of each mutant, followed by hybridization of this labeled RNA to a Typhimurium
genome tiling array. To demonstrate the ability to identify fitness phenotypes using our pool of mutants, the pool was
subjected to selection by intraperitoneal injection into BALB/c mice and subsequent recovery from spleens. Changes in the
representation of each mutant were monitored using T7 transcripts hybridized to a novel inexpensive minimal microarray.
Among the top 120 statistically significant spleen colonization phenotypes, more than 40 were mutations in genes with no
previously known role in this model. Fifteen phenotypes were tested using individual mutants in competitive assays of
intraperitoneal infection in mice and eleven were confirmed, including the first two examples of attenuation for sRNA
mutants in Salmonella. We refer to the method as Array-based analysis of cistrons under selection (ABACUS).
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Introduction
Genetic screening remains one of the most efficient methods to
identify genes associated with a phenotype of interest in bacteria.
Array-based methods for these screens originated with the
transposon-based ‘‘signature tagged mutagenesis’’ (STM) strategy
that used unique signature sequences in each transposon to
evaluate the relative abundance of individual mutants in pools
after selection [1]. STM was later improved by modifying the
mutagenizing transposon to include a T7 RNA polymerase
promoter (PT7) that is used to generate a unique transcript for
each mutant from the genomic sequence adjacent to the mutation.
This modification makes exogenous unique sequence tags
unnecessary. Relative abundance of the input and output PT7
transcripts is monitored using an ORF microarray [2,3,4,5].
Transposon mutagenesis suffers from several drawbacks. First,
tens of thousands of random transposon insertion mutants are
necessary to ensure that mutations occur in most small genes. There
are over 1,100 annotated open reading frames in Salmonella that are
less than 500 bases in length. In mathematical simulations of pools
of 40,000 random transposon integrations, over 200 of these short
genes fail to be disrupted by any transposon, on average (data not
shown). Second, this need for a high complexity is a critical
limitation of random mutants for genetic screens in environments,
including live animals, where the bacterial population may fall to
low levels during infection. These ‘bottlenecks’ may occur at various
points during infection – survival of the acidic environment in the
stomach, invasion of Peyer’s patches and survival in the blood-
stream represent some of the processes where the founder
population may be very small. Such ‘bottlenecks’ cause undesirable
random loss of mutants and complicate forward genetic screening in
such environments. In addition, the polar nature of transposon
insertions makes mapping of a phenotype more difficult.
We used the lambda-red recombination method that includes
features to minimize polarity [6] to construct targeted deletion
mutants in Salmonella. We added a PT7 to the cassette inserted
during mutagenesis, positioned to produce a gene-specific
transcript from the genomic sequence adjacent to the insertion.
Thus, our targeted deletion mutants can be pooled for genetic
screens. Far fewer specific mutants are needed to ensure
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representation of every gene of interest than is needed when using
random transposon mutagenesis. We introduce a novel and
inexpensive array designed for monitoring changes in specific
deletion mutant representation in the pool after selection. Finally,
we demonstrate the utility of these techniques by identifying novel
candidate genes encoding proteins and sRNAs deletions of which
affect fitness in competitive infection with wild-type Salmonella, and
we validate eleven of these fitness phenotypes.
Results
Genome sequencing
The virulent isolate Salmonella enterica serovar Typhimurium
ATCC14028 is extensively studied both in vitro and in vivo. To design
primers for generation of our deletion collection, we produced a
near complete draft sequence of this genome using the 454 shotgun
approach (GenBank accession in process). The ATCC14028
sequence was compared to the completed genome of the 1,000-
fold less pathogenic laboratory strain Typhimurium LT2 [7]. As
expected, over 95% of the two genomes were orthologous, and the
orthologous regions had less than 1% divergence. The ATCC14028
and LT2 genomes differ only by a few hundred single base
mutations (including a mutation in rpoS that is partly responsible for
the attenuation of LT2 [8]), the absence of the two Fels phage in
ATCC14028, and other insertions and deletions encompassing less
than 40 kb (Sandy Clifton et al., unpublished data).
Generation of specific gene deletions in ATCC14028
We targeted 1,052 genes for deletion (Table S1), primarily
genes in Salmonella that are not found in E. coli [7]. Such genes are
usually in very A+T rich regions [9], and include nearly all of the
,200 genes previously associated with Salmonella virulence,
including the Type III secretion systems (TTSS) and their known
effectors. Targeted deletions were also generated in nearly all of
the 100 genes in fimbrial and surface antigen regulons. Finally, we
deleted a subset of genes shared by Salmonella and E. coli, including
44 known and candidate sRNAs, and genes that have known
motility, regulatory and pathogenesis functions.
The original vectors for the lambda-red swap strategy, pKD3
(CmR) and pKD4 (KanR) [6], were redesigned to include a T7 RNA
polymerase promoter positioned to generate a unique transcript from
the Salmonella genome directly downstream of each mutant. The
construct includes an ATG and ribosome binding site (RBS) to
preserve any translation coupling. An outline of our variation on the
lambda-red swap strategy is shown in Figure 1. The sequences of the
redesigned vectors, pCLF3 and pCLF4, are available in GenBank
(Accession numbers EU629213 and EU629214, respectively).
The oligos used for mutagenesis were 65mers that contained the
same 39 sequence of 20 bases for vector PCR that were used
previously [6]. However, they included a 45-base rather than the
conventional 35-base gene-specific portion, to allow a secondary
function for the oligonucleotides as probes in a microarray (described
later). Homology of the oligonucleotides with the genome was
positioned so that each swap eliminated the entire gene except for the
coding regions of 30 base pairs at the 59 and 39 ends of each gene.
These two ends of each gene were preserved to minimize unintended
effects on adjacent genes caused by removal of the gene sequence and
insertion of the mutagenic cassette. If FLP recombination is used to
remove the antibiotic cassette after mutant construction then an open
reading frame is generated including ten codons from the 59 end of
the original gene, 39 amino acids from the lambda-red mutagenesis
referred to as a ‘‘scar’’, and nine amino acids and the stop codon from
the original gene. In our constructs, the T7 promoter remains in place
in the scar after FLP recombination.
We also increased the level of throughput in the generation of
our mutant collections. Lambda-red swap recombination in
ATCC14028 was performed with a mixture of two PCR products,
one originating from pCLF4 containing a kanamycin resistance
cassette (KanR, sense orientation) and one originating from pCLF3
containing a chloramphenicol resistance cassette (CmR, antisense
orientation). Each transformation was plated on LB-Kan and LB-
Cm, and two transformants from each plate were colony purified
and stored (a total of four transformants). These two collections
marked with different antibiotic resistance cassettes facilitate the
construction of double mutants by transduction.
The Salmonella genes targeted for deletion were spot-checked by
PCR. Of 1,052 mutants attempted, 1,040 produced KanR or CmR
clones, or both of which 1023 were confirmed, below (Table S1).
To confirm that mutations occurred at the targeted location, two
clones obtained for the first 304 KanR mutants and for 231 CmR
mutants were checked by PCR using primers to the flanking
genomic regions. Only one mutation was incorrect.
The accuracy of FLP recombination to remove the antibiotic
resistance marker was verified for twelve transformants (as detailed
in the Methods and Materials section). The mutant including
flanking regions was amplified by PCR, and both strands of the
amplification product were sequenced. All twelve swaps examined
were precise, and each recombination event resulted in the
intended truncated open reading frame.
Array-based verification of PT7 location and activity from
a pool of mutants
We used a NimbleGen tiling array to verify the correct insertion
and activity of the PT7 in all of our mutants simultaneously. 1,031
Author Summary
One strategy to define bacterial genes with a role during
infection involves the screening of a pool of random
transposon insertion mutants, where each mutant is
identifiable by a specific motif or unique transcript.
Changes in the survival of each mutant indicate a role of
the mutated region during infection. To ensure coverage
of most genes of interest, a large number of random
transposon mutants would be needed. However, when a
pool of bacterial mutants spreads into different sites in an
animal host, some mutants are lost at random if the
founder population (i.e. the bacteria initially reaching this
site, before expansion) is smaller than the number of
mutants introduced into the animal. This random loss
severely obscures mutants that are truly at a disadvantage.
In order to minimize the number of mutants to be
screened and thus minimize random loss of mutants from
an infecting pool, we generated targeted specific deletions
in each gene of interest. Furthermore, we inserted a
promoter in each mutant that allows simultaneous
monitoring of a pool of these mutants on a novel
inexpensive microarray. To demonstrate the utility of our
technique, a pool of over 1,000 gene-targeted Salmonella
mutants was injected into mice and recovered from
spleens. We identified mutants that were less fit than
wild-type Salmonella in this model. Eleven mutants in
genes that were not previously known to affect Salmonella
fitness in intraperitoneal infection were confirmed using
the individual mutants in competition with wild-type
bacteria. These new phenotypes include the first two
examples of attenuation and one of hypervirulence in
Salmonella due to mutations in small stable RNAs, a class
of regulators that bind to other RNAs and proteins.
Array-Based Analysis of a Pool of Deletion Mutants
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KanR mutants were pooled by growing each mutant separately to
stationary phase in LB, mixing in equal volume, and storing as
glycerol stocks at 280uC. The region 39 to each mutation in the
pool of 1,031 KanR mutants was labeled by a novel method
designed to generate uniform signals from every PT7 (Materials
and Methods and Figure 2). For the necessary DNA fragmen-
tation prior to amplification and labeling, we replaced the
restriction digestion step used in previous protocols with genome
shearing and polyA tailing. To identify active PT7 in the mutants,
labeled RNA obtained by T7 in vitro transcription from the pool
was hybridized to a custom NimbleGen tiling array of 50mer
oligonucleotides covering the ATCC14028 genome in overlapping
24 base steps on both strands. Oligos directly adjacent to each
functional insert and in the opposite strand from the transcript
Figure 2. Labeling technique for detection of mutants in a pool by arrays.
doi:10.1371/journal.ppat.1000477.g002
Figure 1. Generation of specific deletions in S. enterica serovar Typhimurium ATCC14028. Our procedure is identical to the Red-swap
described in reference [6] with the exception that we re-engineered the original insert to include an in-frame T7 RNA polymerase promoter (PT7), and
the sequences used for recombination are longer. A gene, identified in the schematic as genE, is targeted for deletion. Two 65mer primers (red) are
used to amplify the region containing the antibiotic resistance cassette, the PT7, and the FRT sites (among other elements) from the plasmid pCLF4.
The resulting PCR product has 45 base sequences at each end that are homologous to sequences near the 59 and 39 ends of the targeted ORF.
Transformation of these PCR products into ATCC14028 expressing lambda Red recombinase in trans leads to a recombination event resulting in the
swap-in of the PCR product, and swap-out of the targeted gene. A ribosomal binding site (RBS) and a downstream ATG start codon near the 39 end of
the inserted sequence ensures that a 12 amino acid peptide is made from any RNA that is transcribed in this strand to reduce polar effects. Targeted
mutants in many genes were pooled and used for Array-based analysis of cistrons under selection (ABACUS). Finally, antibiotic resistance markers in
targeted genes can be removed using the FLP recombinase resulting in a gene encoding a mini-protein of the first ten amino acids of GenE, 39 amino
acids from the inserted DNA (called a ‘‘scar’’), and the last nine amino acids of GenE, and retaining the PT7.
doi:10.1371/journal.ppat.1000477.g001
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hybridized intensely, with a rapid decrease in signal over a 200
base region (Figure S1). Using this method we simultaneously
identified 933 inserts from KanR mutants with functional PT7 sites
in the correct location. 48 additional KanR mutants are likely
correct but could not be formally confirmed, due to an
overlapping transcript from a nearby mutation in another mutant
in the pool. 50 KanR mutants (4.8% of all pooled mutants) did not
display active transcription at the correct location perhaps due to a
mutation in the PT7. Four inserts were at an incorrect location.
We repeated these experiments with a pool of 972 CmR mutants
and at least 892 of these have a functional PT7. 78 Cm
R mutants
were in genes where a KanR clone was not confirmed. Overall,
correct KanR or CmR mutants, or both, with functional PT7 were
confirmed in 1,023 genes out of 1052 targeted for deletion. We
attempted transduction to construct double mutants of CmR clones
in combination with different KanR clones. All ten double mutants
attempted were successful (data not shown). In addition, the CamR
mutants will also be useful in the future as a pool.
Failure to generate the correct targeted mutation could occur if
the mutation was lethal. We did not attempt to delete any genes
that are orthologous to genes previously reported to be essential in
E. coli [10]. However, we did target 38 genes that were previously
reported as essential in Salmonella [11] and succeeded in obtaining
mutants in all but two; STM1008, a phage gene that has a close
paralogue in the genome, and seems unlikely to be essential in LB,
and STM2087, encoding an enzyme required for the synthesis of
LPS side chains. The reason for the 29 failures to construct a
mutant is as yet undetermined.
Generation and testing of an ‘in house’ microarray for
screening
Pools of our mutants can be studied using competitive assays and
the representation of each mutant can be determined using
microarrays. For such detection, we manufactured an economical
‘‘in house’’ array based on 1,241 65mers derived from the 39 ends of
genes, including all those previously utilized for mutant construc-
tion. As noted earlier, these 65mers contained a 45-base gene-
specific portion, and oligonucleotides of 45 bases in length produce
a more robust RNA hybridization signal [12] than the 35mers that
are normally used for lambda-red recombination [6]. As negative
controls we included in the array 308 65mer oligos with homology
to the 39 end of mutants that had not yet been generated and were
therefore absent from the pool, and 955 65mers designed on the 59
end of genes (previously used for mutant construction).
One aliquot of the pool of 1,031 KanR mutants was used to test
the ‘‘in house’’ array. Labeled RNA probe was prepared from the
pool, and hybridized to the array as described (Materials and
Methods). The 59 ends of these RNA molecules consist of
conserved 27 bases common to every mutant. A specific 27 base
oligonucleotide complementary to this region was included in the
hybridization to block cross-hybridization of this portion of the T7
transcripts to a complementary 20 base sequence present in each
of the 39 gene probes on the array (Figure S2). Specific signal at
least three-fold over the mean signal of the negative controls was
detected for 97% (905) of the 933 mutants known to be in the pool.
Table S2 illustrates the specificity and sensitivity of our approach.
Only seven (0.7%) of the 59 oligos included as negative controls in
the array hybridized, possibly due to a transcript from a nearby
mutant in the complementary strand.
Genes that affect fitness of Salmonella during passage
through BALB/c mice
BALB/c mice develop fatal systemic infection from S. enterica
serotype Typhimurium, as can also occur in humans infected with
S. enterica serotype Typhi. We used intraperitoneal infection in
BALB/c mice, a well-studied model [1,13,14,15,16], to demon-
strate that our mutant screening method could correctly identify
both previously observed and novel gene requirements during
infection. A group of six BALB/c mice were infected intraperi-
toneally (IP) and bacteria were recovered from the spleen after
euthanasia at 48 hours post-infection. Labeled RNA probe was
prepared using aliquots of DNA from the input pool and output
pools from each animal as outlined in Figure 2, and the labeling
protocol was repeated with dyes reversed. Hybridizations were
performed using twelve slides, each slide containing the array
printed in triplicate. The data were processed using WebArray
[17], as described in Materials & Methods, and are presented in
Table S1, and visualized by genome position in Figure 3.
At a threshold of a two-fold change and P,0.0005, 120 mutants
showed a change in fitness in IP infection. Among the most unfit
were mutants in the TTSS encoded by SPI-2, and associated
effector genes, and genes for cell wall biosynthetic enzymes, all
known to be important during systemic infection [1,13]. None of
these mutants have a change in fitness during growth of the pool in
LB for four serial passages to stationary phase with 100-fold
dilutions (data not presented). Fifteen mutants without previously
known fitness phenotypes during systemic infection in BALB/cmice
were selected from the 120 statistically top-ranked candidate
mutants. These included mutants in all five candidate sRNA, a
supernumerary tRNA (LeuX), and nine randomly picked protein
coding genes. These 15 mutants were studied one at a time in
competitive assays with wild-type ATCC14028, after P22 trans-
duction of each mutation to a clean genetic background. The
phenotypes observed in the pool of mutants were confirmed for
eleven mutants, as listed in Figure 4 and Table S3. Four mutants
failed to reiterate the phenotype observed in the mutant pool (sraA,
rybB, STM4529, and STM0857) but this result does not rule out
confirmation of a phenotype in a study involving more animals.
All eleven mutants with confirmed competitive index pheno-
types had their KanR cassette removed by FLP recombination to
reduce the chance of polar effects on nearby genes. Eight of these
(STM1131, STM2303, STM3120, STM3121, sroA, istR, leuX, and
oxyS) were retested in competitive infections in BALB/c mice
(Figure 4A). The phenotype was confirmed in all eight of these
unmarked mutants that should have minimal or no polar effects.
In order to definitively link the deleted genes to the reduced
fitness phenotype, two of our unmarked (‘‘FLP-ed’’) mutants
(DSTM2303::FRT and DSTM3121::FRT) were re-tested after
complementation in trans. Intact copies of these genes were cloned
into a stable low copy plasmid vector, pWSK29 [18], and the
complementing plasmids were transformed into the corresponding
unmarked deletion strains. The competitive fitness defect of both
mutants was reversed when these strains were complemented with
an intact copy of the corresponding gene in trans (Figure 4B). The
presence of the vector alone did not improve the fitness of these
two mutants during infection.
Discussion
Targeted deletion by lambda-red recombination was previously
used to construct a library of specific gene deletion mutants for E.
coli [10]. Here, we use this approach for Salmonella, and modify it
by adding a T7 RNA polymerase promoter to the insert for the
generation of unique transcripts from each mutant. These
transcripts are used to identify and measure the relative
abundance of each mutant from a pool containing all of our
mutants. Furthermore, we introduce several technical innovations
to improve the throughput of library construction, and the labeling
Array-Based Analysis of a Pool of Deletion Mutants
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and detection of transcripts from each mutant on an inexpensive,
customized microarray. We use a well-studied model, systemic
infection of BALB/c mice, to validate our assay and identify novel
candidate genes that affect the fitness of Salmonella in that infection
model.
Our targeted deletion strategy has several important advantages
over screening of pools of mutants made by random transposon
mutagenesis. Screening targeted deletion pools reduces the
complexity of the bacterial pool necessary to cover all genes of
interest by at least 10-fold over random transposon mutant pools;
mathematically, 40,000 random transposon mutants cover about
90% of all non-essential Salmonella genes, whereas 4,000 specific
mutants in each non-essential gene provides 100% coverage of the
targeted genes. This less complex pool is highly advantageous for
forward genetic strategies in circumstances where population sizes
drop during the selection process, such as in animal models
[4,19,20,21,22]. For Salmonella, this ‘‘bottleneck’’ is particularly
severe in the transition from the intestinal tract to the systemic
circulation [23,24] and perhaps in different parts of the
gastrointestinal tract where niche conditions can vary consider-
ably. These bottlenecks cause random loss of mutants from the
pool if the population falls to numbers close to the complexity of
the interrogated pool. For example, if a population falls transiently
to 40,000, then a pool of 4,000 should not lose any mutants
(P,0.01 for loss of one mutant). However, 40,000 mutants will
lose about 37% of its members at random, because the probability
of not picking a mutant that has a frequency of 1/40,000 in 40,000
attempts is (1-1/40,000)40,000 = 0.37. Furthermore, a pool of lower
complexity may be used at a lower infectious dose, allowing a
more physiologically relevant infection. The smallest possible pool
that includes each mutant of interest is therefore highly desirable.
In any particular experimental system the size of the inoculum
needed to avoid bottlenecks will have to be determined
empirically. It is possible to determine the optimum size of the
inoculum and ascertain whether or not there is a bottleneck by
including a ‘‘neutral’’ mutant carrying a different antibiotic
marker at the same CFU as the average mutant CFU in the pool
in each experiment. If the representation of this marked strain
varies dramatically (either highly over- or under-represented) in
the recovered samples in this ‘‘fluctuation test’’, then the inoculum
is of insufficient size to prevent random loss from a pool of that
complexity (McClelland et al., unpublished data).
Random transposons can generate pronounced downstream
effects that contribute to selection. Our targeted in-frame deletions
are engineered to minimize or eliminate these effects. Desirable
existing features of the cassette inserted by lambda-red recombi-
nation [6], such as an internal ATG start codon at the end of the
inserts to allow downstream translational coupling, and the
inclusion of FRT sites for the removal of the antibiotic cassette
by FLP recombination, remain intact. In our construct, FLP
recombination results in the production of an in-frame mini-
protein that uses the original start and stop codons of the deleted
protein, while retaining the PT7. The first and last 30 bases of each
targeted gene were maintained to reduce the chance that targeted
deletions disrupt adjacent genes, overlapping genes, and cis-acting
sequences thus further minimizing the risk of polar effects.
Subsequent analyses should consider that in rare cases the
remaining mini-protein may retain some function. Finally,
confirmation of mutants identified by genetic screening requires
the generation of targeted mutations. A targeted deletion library
allows independently generated mutants in the gene of interest to
simply be picked from the ordered collection of mutants for further
analysis.
Earlier labeling strategies for T7 transcripts from transposon
libraries use restriction digestion to fragment the genomic DNA,
which has the effect of producing shorter labeled transcripts that
are easily mapped near the PT7 [2,3,4,5]. This approach results in
non-uniform labeling of transcripts, because those transposons that
are not in the ideal proximity to a restriction site are poorly
sampled. Our labeling strategy uses randomly sheared ends,
Figure 3. Loss of defined mutants from the input pool after intraperitoneal delivery to six BALB/c mice and recovery from spleen at
48 h post-infection. Twelve array hybridizations were performed using two each for six mice. WebArray analysis results using quantile
normalization for all oligos representing candidate deletions in the pool are shown. Data with P,0.0005 are depicted in red, those with P.0.0005 in
grey. The X-axis plots the data for each of the mutants in the order in which those mutants occur in the Salmonella genome. Mutants confirmed
individually in a competitive assay with wild-type are labeled in blue. Examples of important genetic elements are marked in black.
doi:10.1371/journal.ppat.1000477.g003
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resulting in more uniform and consistent labeling efficiency for
every mutated gene.
The presence of a PT7 promoter in each targeted mutant allows
the presence and the level of each individual mutant to be tracked
when mutants are pooled, using the mutant-specific transcript
produced from this promoter. This innovation eliminates the need
to introduce a different ‘signature’ sequence in each of the mutants
in the collection. The PT7 facilitates efficient RNA synthesis only
Figure 4. Competitive Index experiments with individual mutants versus wild-type after intraperitoneal delivery and recovery from
the spleen, liver, and cecum. 106 cfu of 933 mutants (pool) or a 1:1 mixture of individual mutants versus wild-type ATCC14028 DphoN::kan were
injected into 5–6 mice and recovered from spleen one or two days post infection. Statistical significance was determined using a Student’s 2-tailed t
test, and asterisks indicate that normalized output ratios were significantly statistically different from the equivalent ratio in the inoculum. ** P value
of ,0.001, * P value of ,0.05. Strains marked with (FRT) have undergone FLP-mediated recombination to reduce or eliminate polar effects. A.
Confirmation of mutants, identified by ABACUS, in competitive infections in BALB/c mice. ABACUS prediction for selected mutants (black bars) and
confirmation data from competitive infections in BALB/c mice (dark blue bars are from spleen, lighter blue are from liver and cecum) of infected
animals. B. Complementation of DSTM2303::FRT and DSTM3121::FRT mutants in trans. The predictions from ABACUS are indicated as black bars. For
complementation experiments animals were infected with either a 1:1 mixture of the mutant bearing pWSK29 vs. ATCC14028 DphoN::kan (negative
control, blue bars) or the mutant bearing the corresponding complementing gene on pWSK29 vs. the wild-type ATCC14028D phoN::kan
(complemented, grey bars).
doi:10.1371/journal.ppat.1000477.g004
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from those DNA fragments that contain PT7. Any artifacts that
might be generated during the tailing and PCR steps are not
transcribed. Our PT7 procedure generates primarily single
stranded labeled RNA, minimizing competition for hybridization
to the oligonucleotide array, which might be one reason that the
performance of this protocol was consistently superior to direct
labeling of PCR products in detection sensitivity and in the
standard deviation of measurements, as measured by microrray
(data not shown).
The presence of the T7 RNA polymerase promoter in each
mutant construct allowed us to check all candidate mutants
simultaneously for the location of a functional PT7. Using a
NimbleGen tiling array of 387,000 oligonucleotides, we confirmed
933 of 1,031 mutants in the Kan R pool as present in exactly the
correct place, and functional, simultaneously. Similarly, 892 of 972
CmR mutants were confirmed using this technique. Thus, we
bypassed much more expensive and laborious traditional PCR
confirmation. We also confirm the activity of the PT7, which is not
possible using PCR.
For routine hybridizations of the pool, we constructed an
inexpensive oligonucleotide microarray using the same oligonucle-
otides that we used to construct the mutants, containing 45 bases of
homology to the Salmonella genome. This array could also be used to
confirm the presence of nearby active PT7 in a pool. However,
unlike the NimbleGen array, this minimal array does not prove the
location of the inserted cassettes, or find extraneous insertions that
occur elsewhere in the genome. Fortunately, the more expensive
NimbleGen arrays need only be used once to determine which
mutations are in the correct location and have an active PT7. After
the library is characterized, the less expensive in-house arrays can be
used for further experiments without ambiguity. We expect that
multiplexed high-throughput sequencing of experimental samples
will replace arrays as the method for assessing changes in the T7
transcripts as soon as prices become competitive.
In order to test our targeted deletion collection and novel
protocols, we used systemic infection of BALB/c mice, a model
system that has been studied extensively using transposon libraries
[1,13,14,15,16]. All the mutants in our collection that were reported
to have attenuated growth in these previous transposon assays were
confirmed in our assay, including those in SPI-2 and lipopolysac-
charide biosynthesis genes. In addition, among the 120 mutants
showing the strongest fitness phenotype we identified more than 40
candidates with no previously known phenotype in this model,
although many of these new candidate phenotypes are generally
more subtle than those seen for SPI-2 (Table S1, Figure 3).
We retested fifteen of the novel mutants with at least a 2-fold
change in representation between the input and output pool
(P,0.0001) in individual competitive infections, and eleven were
confirmed in mutants containing the antibiotic cassette. We
retested eight of these mutants (STM1131, STM2303, STM3120,
STM3121, sroA, istR, leuX and oxyS) after removal of the antibiotic
resistance cassette. The reduced competitive fitness seen in the
mutants containing an antibiotic resistance cassette was also seen
in all eight of these mutants after removal of this cassette
(Figure 4A and Table S3). We complemented two of these novel
mutants, STM2303 (pmrM) and STM3121 (a LysR-type transcrip-
tional regulator), with the corresponding intact open reading
frames in trans. The complemented mutants were found in the
spleen in numbers similar or greater than the wild-type
(Figure 4B). These findings directly and unambiguously link the
genes we complemented here to the observed defect in fitness of
the corresponding mutant during competitive infection with the
wild-type. Thus, most of the remaining 25 mutants of the original
top 40 novel candidates that we identified may have a phenotype
in this BALB/c acute systemic infection model. There are likely to
be further phenotypes yet to be discovered among the many genes
that were not mutated for the experiments performed here.
Using our method, the overall false negative rate (failure to
observe phenotypes for mutants already known to be under strong
selection in this model and measured on the array) was zero. Among
120 mutants showing a phenotype with P,0.0001 and a greater
than two-fold change, more than half are already known to have a
phenotype and among the new candidates, eleven out of fifteen
were confirmed. Thus, the false discovery rate is very low. However,
the false discovery rate for new mutants in a system that is already
well studied is invariably high. When most genes with a role in a
process are known, only a few phenotypes remain to be discovered
among the thousands of genes that have no phenotype in that
process. The future rate of discovery in the intraperitoneal model in
BALB/c mice is unlikely to be better than the rate of 11 out of 15
that we experienced. The rate of confirmation of mutants that show
a weaker statistical confidence and lower fold-difference in fitness is
likely to be worse. In addition, those mutants with subtle phenotypes
in an animal will require a larger number of biological replicates in
order to establish the phenotype with confidence. Other phenotypes
that will be missed by using a pool of mutants are any of those
rescued, in trans, by the presence of wild-type bacteria.
Of the mutants we confirm in individual competitive infections
with wild-type, four were in small RNA molecules. Mutations in
leuX, encoding a minor tRNA-Leu, were previously known to
reduce the expression of Type I fimbriae, and reduce bladder
epithelial invasion and intracellular proliferation of Uropathogenic
E. coli [25,26]. The attenuation of a leuX deletion during Salmonella
infection was previously unknown. Mutants in the regulatory
sRNAs IstR, OxyS and SroA showed small, but reproducible,
phenotypes in our in vivo experiment, and all have orthologs in E.
coli. In E. coli, IstR inhibits the translation of tisAB, an SOS-induced
toxic peptide, and may arrest growth allowing DNA repair
[27,28,29,30]. SroA is a known regulator of the thiBPQ operon in
E. coli, that encodes an ABC transport system for the import of
thiamine and thiamine pyrophosphate (TPP) into the cell [31]. TPP
is an essential cofactor for key enzymes in carbon metabolism.
The oxyS mutant was one of the few examples of a mutant that
displayed an increase in fitness in vivo in our screen. OxyS is a
member of the OxyR regulon expressed during oxidative stress.
This sRNA is a pleiotropic regulator of about 40 genes in E. coli
including rpoS, and an anti-mutator that may inhibit alternate
stress adaptation pathways when OxyR is activated [30,32]. Our
observations for OxyS, SroA, and IstR, are the first examples of
phenotypes for small non-coding RNA mutants during Salmonella
infection, other than the tmRNA system that targets proteins for
degradation [33]. The targets of these sRNAs in Salmonella are not
fully known, and given, for example, the recently reported variable
composition of the PhoP regulon across related organisms [34],
may differ significantly from their targets in related organisms.
Of the seven remaining confirmed mutant phenotypes, four are
in genes that encode putative membrane proteins (STM1131,
STM2120, STM2215 and STM2303), and a fifth gene (STM1760)
encodes a putative secreted protein. STM1131 encodes a member
of the KdgM superfamily (oligogalacturonate-specific porin). A
paralog of this gene, STM4016 (yshA, 26% identity, 40% similarity)
is involved in O-Antigen capsule production and environmental
persistence [35]. Mutants in a second membrane protein,
STM2120 (asmA), are highly sensitive to gastric contents of swine,
but otherwise little is known of the function of this gene in
Salmonellae [36]. Mutants in the E. coli orthlog of asmA are
extragenic suppressors of outer membrane protein assembly and
have less LPS on the bacterial surface [37]. A third gene encoding
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a predicted membrane protein, STM2215, is one of at least eight
proteins encoded by Typhimurium that contain cyclic-di-GMP
phosphodiesterase, or EAL domains (named after the amino acids
in the conserved domain). Unlike several other EAL-containing
proteins, mutations in STM2215 do not influence a multicellular
behavior known as the rdar morphotype [38]. Our work reports
the first phenotype of any kind for STM2215.
Finally, STM2303 (pmrM; pbgE3) is the terminal gene in the pmr
operon (polymyxin resistance) and also encodes a predicted
membrane protein. This operon is involved in 4-aminoarabinose
addition to Lipid A, a modification that confers resistance to
polymixin [39]. Paradoxically, PmrM does not appear to be
necessary for this function [39,40], but may be important for
resistance of Salmonella to high iron concentrations in vitro [41,42].
Recent studies show that mutants in STM2303 have reduced
expression of hilA, an important regulator of virulence genes in
Salmonella, and reduced invasion in T84 human colonic epithelial
carcinoma cells [43].
Mutants in STM1760, encoding a protein containing a classical
N-terminal secretion signal sequence, were also confirmed as
selected against in our competitive infection assays. The protein
encoded by this gene contains multiple Tricopeptide Repeats
(TPR) of the Sel-1 superfamily, a motif that mediates protein-
protein interactions [44]. Nothing further is reported in the
literature about this protein and its potential role during systemic
infection by Salmonella.
The final genes we confirmed to be important during systemic
infection in BALB/c mice, STM3120 and STM3121, are
neighboring in the genome. STM3121 is a LysR family
transcriptional regulator neighboring STM3120 but is transcribed
in the opposite direction. Interestingly, expression of STM3121 in
trans appeared to increase fitness during infection (Figure 4B).
STM3121 has not previously been reported to be important during
Typhimurium infection, and determination of its regulatory
targets may reveal clues as to its role during infection.
STM3120 and several adjacent genes (cluster STM3120-
STM3117) are present in serotypes Typhimurium, Enteritidis,
and Gallinarum [45] and in some Yersinia [46], but are not present
in the typhoidal Salmonellae or other enterobacterial species studied
to date. A second gene in this group, STM3119, was also selected
against during our ABACUS screen (Table S1). Proteomic and
transcriptional data indicates that the proteins encoded in this
region are highly up-regulated in macrophages [47,48,49]. In
serotype Enteritidis, these genes are essential for growth in chicken
macrophages and mutants in some of these genes in Gallinarum
are defective for systemic colonization after oral infection in
chickens [45,50].
Although STM3120 is a predicted citE (citrate lyase) homolog, the
other two subunits (citD encoding the a-subunit, and citF encoding
the c-subunit) that normally make up bacterial ATP-dependent
citrate lyase are not encoded in the region containing this gene. This
suggests that STM3120 may have a different function than a
traditional citrate lyase. In Yersinia pestis, homologs of STM3120-
3117 are necessary for survival in macrophages that are activated
with c-interferon after infection. These genes appear to function in
Y. pestis by lowering the level of nitric oxide in macrophages without
affecting iNOS levels in c-interferon post-treated macrophages [46].
It is possible that these genes play a similar role in Salmonella, but this
hypothesis remains to be investigated.
To summarize, we have designed a collection of novel
technologies that permit easy generation and confirmation of
specific deletion mutants for genetic screening, both individually
and in pools. Use of our collection, designed to minimize the
effects of population bottlenecks on screening, will allow relevant
animal models and more relevant doses to be efficiently used to
identify Salmonella mutants with altered fitness in vivo. During our
testing of this approach, eleven of such mutants were confirmed in
individual competition assays, including three sRNAs and leuX.
The tools used here are a first step to a more complete description
of Salmonella genes involved in systemic infection in mice,
particularly those genes with milder phenotypes that were difficult
to identify with confidence in previous studies. These tools are also
of wide applicability to identify genes involved in other aspects of
Salmonella biology. Finally, similar strategies can be applied in other
genetically malleable bacteria.
Materials and Methods
Ethics statement regarding the use of animals, choice of
species, and numbers of animals
The search for new mechanisms in infection has no in vitro
surrogate. Mice are natural hosts for Salmonella and are also a
potential source of human infection. The library and pooling
strategies with microarray output (ABACUS) reduces the number
of animals required to obtain mutant phenotypes by at least three
orders of magnitude compared to screening individual mutants.
Veterinary care
All animals were housed in AAALAC-accredited animal
research facilities at Texas A&M University and were observed
daily for assessment of animal health. The facilities are in
compliance with the standards set forth in the PHS ‘‘Guide for
the Care and Use of Laboratory Animals’’.
Methods for pain and stress relief
If during the course of these experiments any animal showed
anorexia for greater that 24 hr., disinclination to move for
12 hours, loss of normal neurological function as evidenced by
locomotory or balance deficits then euthanasia was performed
using CO2 (.70%, inhaled) in accordance with the 2000 AVMA
Guide for Euthanasia.
Strains and standard culture conditions
All strains used in this study are derivatives of Salmonella enterica
serovar Typhimurium ATCC14028 (Manassas, VA). Strains were
routinely cultured in Luria-Bertani (LB) broth and plates,
supplemented with 50 mg/l Kanamycin (Kan), 20 mg/l Chloram-
phenicol (Cm) or 100 mg/l Ampicillin (Amp) where appropriate.
Construction of plasmids with T7 RNA polymerase
promoters
We used a PCR-based strategy to include a T7 promoter in the
original pKD3 (CmR) and pKD4 (KanR) vectors for the lambda-red
recombination method. Briefly, pKD3 and pKD4 were used as
template for independent PCR reactions using primers PT72_E-
coRI (ACTCGAATTCCGAAATTAATACGACTCACTATAG-
GGAGACCTAAGGAGGATATTCATATG) and FRT3-EcoRI
(CATCGAATTCCTATTCCGAAGTTCCTATTCTCTAGAA-
AGTATAGGAACTTCGGCGCGCCT) or primers PT72-EcoRI
and FRT4-EcoRI (CATCGAATTCCTATTCCGAAGTTCC-
TATTCTCTAGAAAGTATAGGAACTTCAGAGCGCT), re-
spectively. The EcoRI sites are underlined and the PT7 is in bold.
Each PCR product was digested with EcoRI, gel purified and self-
ligated. Electrocompetent E. coli EC100D pir-116 (Epicentre), was
transformed with aliquots of the ligation, and transformants were
selected at 37uC on LB Cm or LB Kan plates. The sequence (both
strands) of the resulting plasmids pCLF3 and pCLF4 was
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determined by the conventional dye-terminating Sanger method,
and deposited under GenBank accession numbers EU629213 and
EU629214, respectively.
Generation of specific deletion mutants
Deletion strains were generated using the lambda-red recombi-
nase method [6], with the following modifications, as illustrated in
Figure 1. Plasmids pCLF3 (CmR) and pCLF4 (KanR) were used
as templates to generate unique PCR products for deletion of each
gene of interest. The primers used are shown in Table S1. PCR
amplifications were carried out in 96 well plates using ExTaq
polymerase (Takara) in a total reaction volume of 60 ml, and a
PCR reaction of 30 cycles at an annealing temperature of 55uC.
For each gene to be deleted, 30 ml of both PCR products bearing
different antibiotic markers were combined and purified using the
Qiaquick PCR purification kit in 96 well format (Qiagen). Mixed,
purified PCR products (10 ml) were dialyzed against sterile water
for 10 minutes using filters with 0.025 mM pore size (Millipore). 2–
5 ml of mixed, purified PCR products were used for transforma-
tion by electroporation (Bio-Rad Gene Pulser) of electrocompetent
ATCC14028 expressing lambda-red recombinase, prepared as
previously described [6]. Transformations were allowed to recover
for 3 hours in LB at 37uC and 150 ml of each transformation was
plated on LB Kan and LB Cm plates. The remaining
transformation was saved and replated when very few colonies
were obtained using the shorter grow out period. Two transfor-
mants for each gene and each antibiotic resistance marker were
twice colony purified, and stored in 30% glycerol at 280uC. The
KanR mutants characterized here are available to the community.
Labeling technique, part I: DNA isolation, sonication and
polyadenylation
Our labeling protocol is outlined in Figure 2. Genomic DNA
was prepared for the input and output pools of ,1000 mutants
using the GenElute Bacterial Genomic DNA kit (Sigma). 4 mg of
genomic DNA was fragmented by sonication using twenty pulses of
two seconds in a Branson Sonifier 150 (Branson Ultrasonics Corp.,
Danbury, CT). PolyA tails were added to fragmented genomic
DNA using terminal transferase (TdT) as follows: 1.5 mg of DNA
fragments were incubated for 30 min at 37uC in a total reaction
volume of 50 ml containing 40 U TdT (New England BioLabs.),
CoCl2 0.25 mM, and dATP 0.4 mM. Terminal transferase was
subsequently inactivated at 70uC for 10 min and the tailed product
was purified using the QIAquick PCR purification kit (Qiagen).
Labeling technique, part II: PCR amplification and
labeling of fragments adjacent the deletion location
Nested PCR was used to amplify the polyA-tailed DNA
fragments containing the insert PT7 and the flanking inserted
region. In the first PCR reaction, 50 ng of purified polyA-tailed
DNA was used as template for a PCR reaction using primer FRT
Out 3-1 (TTCCTATACTTTCTAGAGAA), and a primer de-
signed to anneal to the polyA-tail (CCT24VN). The reaction
mixture consisted of 16 PCR buffer, 0.2 mM of dNTP, 1.5 mM
MgCl2, 0.05 U Taq polymerase (Promega, WI), and 0.2 mM of
each forward and reverse primer in a total reaction volume of 25 ml.
The PCR reaction was performed under the following conditions:
initial denaturation at 94uC for 1 min followed by 30 cycles with
denaturation at 94uC for 10 s, annealing at 50uC for 10 s, and
extension at 72uC for 5 s. The last cycle was followed by a final
extension for 3 min at 72uC. In the second amplification step, a
nested PCR was performed using 1 ml amplified product from the
initial PCR in a total volume of 50 ml. Internal primer FRTOut 3-2
(TAGGAACTTCGGAATAGGAA) and primer CCT24VN were
used under identical cycling conditions as during the initial PCR
reaction. PCR products were analyzed on 1% agarose gels.
An aliquot of 8 ml of the nested PCR reaction was used directly
as template for a 20 ml in vitro transcription reaction using the
AmpliScribe T7 transcription kit (Epicentre), following the
manufacturer’s protocol with some modifications. The RNA was
labeled during the synthesis by including 2 ml of 5 mM Cy5- or
Cy3-UTP (GE Healthcare) in the in vitro transcription reaction.
Labeled RNA was treated with RNase-free DNase (Epicentre) and
purified with the RNeasy Mini Kit (Qiagen).
NimbleGen microarray hybridization
Hybridizations were performed according to the manufacturer’s
protocols (NimbleGen Systems,Madison,WI, http://www.nimblegen.
com/products/lit/lit.html, cgh_userguide_2008_05_27[1].pdf) with
some modifications. For each hybridization, 4 mg of labeled RNA
was mixed with alignment oligo, NimbleGen hybridization compo-
nents and hybridization buffer. The arrays were hybridized at 42uC
for 16 hours. Arrays were washed according to the manufacturer’s
protocol, and scanned using a GenePix 4000B laser scanner
(Molecular Devices, Sunnyvale, California) at 5 mm resolution. The
signal intensities were quantified using NimbleScan software v2.4
(NimbleGen Systems). The data was normalized and analyzed using
Webarray [17] and WebarrayDB (www.webarraydb.org), with
quantile normalization. The moving median intensity of five adjacent
probes on the same strand in the genome was calculated and plotted
against the genome annotation. Peaks were identified visually
(Figure S1).
In-house array hybridization
The 933 65mer 39 oligos and over 1000 control oligos were
printed at 10 mg/ml in 50% DMSO on Corning UltraGap II slides
in triplicate arrays. Oligo sequences are inTable S1, and the arrays
deposited in GEO as platform GPL5687 and GPL5688. Array
hybridization was performed in hybridization chambers (Corning
Inc., Corning, NY), following protocols suggested by the manufac-
turer for hybridizations in formamide buffer for pre-hybridization,
hybridization, and post-hybridization washes (http://www.corning.
com/Lifesciences/technical_information/techDocs/gaps_ii_manual_
protocol_5_02_cls_gaps_ 005.pdf). Immediately before hybridiza-
tion, 2 mg of the labeled probes for input and 2 mg of each
experimental sample were unified in 36.5 ml, mixed with 3.5 ml of
100 mM 27mer competitor oligo (CATATGAATATCCTCCT-
TAGGTCTCCC) complementary to the 27 bases of RNA
produced by every mutant (Figure S2), and 40 ml of 26
hybridization buffer (50% formamide, 106 SSC [16 SSC is
0.15 M NaCl plus 0.015 M sodium citrate], 0.2% sodium dodecyl
sulfate) and then denatured at .96uC for 5 min. The probes were
hybridized to the Salmonellamicroarray overnight at 42uC in a water
bath.
After overnight incubation, slides were washed and scanned
using the ScanArray 5000 laser scanner (Packard BioChip
Technologies, Billerica, Mass.) with ScanArray 2.1 software.
Fluorescence signal intensities were quantified using the Quan-
tArray 2.0 software package (Packard BioChip Technologies). The
data were subsequently analyzed using Webarray [17] (www.
webarraydb.org), with quantile normalization.
Recombination between FRT sites using FLP
recombinase
Antibiotic resistance cassettes were removed from targeted
deletion mutants as previously described [6]. Briefly, each mutant
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was transformed with the temperature-sensitive plasmid pCP20,
that encodes FLP recombinase [51]. Transformants bearing the
plasmid were selected at 30uC on LB Ampicillin plates. Several
colonies from each transformation were streaked twice and grown
at 37uC on LB plates (without antibiotics). Loss of the antibiotic
resistance cassettes was determined by patching candidate strains
on LB containing the appropriate antibiotics (either Kan or Cm).
The concomitant loss of plasmid pCP20 was confirmed by
patching the candidate mutants on LB Amp plates.
In our mutant collection, the recombination event leaves ten
codons from the 59 end of the original gene, a 39 codon region
containing the PT7 (referred to as a ‘‘scar’’), and the final ten
codons of the original gene (Figure 1). Scarred derivatives of
mutants DSTM0854::kan, DSTM1402::kan, DSTM2840::kan,
DSTM2884::kan, DSTM2581::kan and DSTM2581::cam were
generated to ensure the accuracy of FLP recombination. Two
independent examples of each mutant were picked and the
presence of each scarred mutant allele was confirmed by PCR
amplification using primers flanking mutation, and the subsequent
sequence of both strands of the PCR product was obtained by the
conventional dye-terminating Sanger method. Non-resistant
scarred derivatives of mutants DleuX::kan, DsroA::kan, DistR::kan,
DoxyS::kan, DSTM1131::kan, DSTM2303::kan, DSTM3120::kan, and
DSTM3121::kan were generated for further testing in mice.
Construction of complementing plasmids
STM2303 was amplified for complementation using the following
primers: STM2303 forward primer 59 GGCGTCTGGTAC-
CAATTCAGTAT 39, and STM2303 reverse primer 59 TGT-
TCTGGATCCGTGCGATAGC 39. The resulting 947 base pair
PCR product, in which the only full length ORF is STM2303, was
purified using agarose gel electrophoresis and extracted from the gel
using the Qiaquick gel extraction kit (Qiagen). STM3121 was
amplified for complementation using the following primers:
STM3121 forward primer 59 GCTATTTTCAGGGTA-
CCGTTTGGTCG 39, and STM3121 reverse primer 59
GCTCCGTTAGCGGATCCTTTAGACAC 39. The resulting
1,266 base pair PCR product was purified by agarose gel
electrophoresis, and extracted from the gel using the Qiaquick gel
extraction kit (Qiagen). The PCR product contains the full-length
STM3121 open reading frame (879 bp) with approximately 296 bp
of upstream and 90 bp of downstream sequence.
Purified PCR products were digested with KpnI and BamHI and
ligated into pWSK29 previously cut with the same enzymes and gel
purified. E. coli DH5a was transformed with each ligation, and
positive clones were selected on LB plates containing Ampicillin.
Plasmids bearing the correct insert from each cloning were found by
identification of fragments of the proper size after digestion with PvuI.
pWSK29, pWSK29::STM2303, and pWSK29::STM3121 were
transformed into S. Typhimurium strain LB5000 (restriction2,
modification+) [52]. Plasmid DNA was prepared from LB5000
plasmid-bearing transformants using the Qiaprep spin Miniprep kit
(Qiagen), and purified plasmid DNA was used to transform
DSTM2303::FRT and DSTM3121::FRT mutants using heat shock.
Plasmid-bearing deletion mutants were selected on LB Amp plates,
and were twice colony purified prior to use for infections.
Animal studies in BALB/c mice
The pools of ,1,000 mutants used as inocula were grown
overnight at 37uC in LB with aeration and serially diluted in PBS
to the proper concentration for inoculation, and the titer of the
inoculum was determined by plating on LB containing Kanamy-
cin. A group of 6 BALB/c mice (8–10 week old female) was
infected intraperitoneally with 16106 CFU of the pool in 100 ml
PBS. Mice were monitored twice daily for signs of infection, and
were humanely euthanized at 48 hours post infection. Immedi-
ately after euthanasia, the spleen was removed and homogenized
in 5 ml sterile ice cold PBS. 100 ml of the spleen homogenate was
used for serial dilution and titer on LB Kan plates. The bacteria in
the remaining homogenate were grown in LB to stationary phase
and total DNA was extracted.
Individual mutants with an apparent phenotype in the pools
were chosen for confirmation in mixed infections with wild-type
strain HA431 (ATCC14028 phoN NalR), to determine the
competitive index. Inactivation of phoN, encoding alkaline
phosphatase, abolishes the ability to cleave 5-bromo-4-chloro-3-
indolyl phosphate (XP), but does not reduce the ability of serotype
Typhimurium to colonize organs or reduce fecal shedding of this
organism in mice during competitive infections [53]. Growth on
LB agar plates supplemented with XP thus provided an easy
means to distinguish between individual mutants (PhoN+ blue
colonies) and HA431 (PhoN2 white colonies).
Prior to further analysis, the mutant allele present in each
individual mutant to be confirmed was transferred to HA420
(ATCC14028 NalR) by P22 transduction. Mutant strains and our
wild-type strain HA431 were grown overnight at 37uC with aeration,
mixed in a 1:1 ratio, and serially diluted in PBS to the proper
concentration for inoculation and titer. Titer was used to determine
the exact ratio of strains administered. Groups of 4–6 BALB/c mice
(8–10 week old female) were infected intraperitoneally with
16106 CFU of mutant and wild-type virulent HA431 in 100 ml
PBS. Mice were euthanized and spleens, livers, and ceca were
recovered as above. Mutant and wild-type organisms were
enumerated by serial dilution and plating on LB plates containing
20 mg/L of XP.
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